JP2015508780A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015508780A5 JP2015508780A5 JP2014557870A JP2014557870A JP2015508780A5 JP 2015508780 A5 JP2015508780 A5 JP 2015508780A5 JP 2014557870 A JP2014557870 A JP 2014557870A JP 2014557870 A JP2014557870 A JP 2014557870A JP 2015508780 A5 JP2015508780 A5 JP 2015508780A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- composition
- administering
- immunocompromised patients
- inhaler
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010061598 Immunodeficiency Diseases 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 4
- 229940071648 Metered Dose Inhaler Drugs 0.000 claims 2
- 239000007922 nasal spray Substances 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 229940112141 Dry Powder Inhaler Drugs 0.000 claims 1
- 208000006572 Human Influenza Diseases 0.000 claims 1
- 206010022000 Influenza Diseases 0.000 claims 1
- 229940097496 Nasal Spray Drugs 0.000 claims 1
- 206010054979 Secondary immunodeficiency Diseases 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 201000009910 diseases by infectious agent Diseases 0.000 claims 1
- 238000002650 immunosuppressive therapy Methods 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 201000002367 primary immunodeficiency disease Diseases 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 238000005507 spraying Methods 0.000 claims 1
Claims (10)
- 免疫不全患者のパラインフルエンザ又はインフルエンザ感染を低減又は処置するために前記患者の気道に投与される医薬製造のための組成物の使用であって、前記組成物が治療有効量のタンパク質を含み、前記タンパク質が配列番号１又は２を含むことを特徴とする使用。
- 前記免疫不全患者には、原発性免疫不全症を患っている患者が含まれる、請求項１に記載の使用。
- 前記免疫不全患者には、続発性免疫不全症を患っている患者が含まれる、請求項１に記載の使用。
- 前記免疫不全患者には、免疫抑制療法で処置されている又はされたことがある患者が含まれる、請求項１に記載の使用。
- 前記免疫不全患者には、化学療法剤で処置されている又はされたことがある患者が含まれる、請求項１に記載の使用。
- 前記投与が、鼻腔スプレーの使用によるものである、請求項１に記載の使用。
- 前記投与が、吸入器の使用によるものである、請求項１に記載の使用。
- 前記投与が、ネブライザー、気化器、気管内チューブ、鼻腔スプレー、ドライパウダー吸入器、加圧噴霧式定量吸入器、又は呼吸作動式加圧噴霧式定量吸入器によるものである、請求項１に記載の使用。
- 前記組成物が液体の形態である、請求項１に記載の使用。
- 前記組成物がドライパウダーの形態である、請求項１に記載の使用。
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261600545P | 2012-02-17 | 2012-02-17 | |
| US61/600,545 | 2012-02-17 | ||
| US201261727627P | 2012-11-16 | 2012-11-16 | |
| US61/727,627 | 2012-11-16 | ||
| PCT/US2013/026754 WO2013123521A1 (en) | 2012-02-17 | 2013-02-19 | Methods, Compounds and Compositions for Treatment of Parainfluenza Virus in Immunocompromised Patients |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015508780A JP2015508780A (ja) | 2015-03-23 |
| JP2015508780A5 true JP2015508780A5 (ja) | 2016-04-21 |
Family
ID=48984833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014557870A Pending JP2015508780A (ja) | 2012-02-17 | 2013-02-19 | 免疫不全患者のインフルエンザ及びパラインフルエンザウイルスを処置するための方法、化合物、及び組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US20130280332A1 (ja) |
| EP (1) | EP2841092B1 (ja) |
| JP (1) | JP2015508780A (ja) |
| CN (2) | CN104203267A (ja) |
| AU (3) | AU2013221230A1 (ja) |
| CA (1) | CA2864746A1 (ja) |
| ES (1) | ES2970401T3 (ja) |
| HK (1) | HK1207975A1 (ja) |
| IL (2) | IL234116B (ja) |
| WO (1) | WO2013123521A1 (ja) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2569434B1 (en) | 2010-05-14 | 2019-09-04 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for treating leukemia and related disorders |
| WO2011143657A1 (en) | 2010-05-14 | 2011-11-17 | Dana-Farber Cancer Institute, Inc. | Male contraceptive compositions and methods of use |
| BR122014024883A2 (pt) | 2010-05-14 | 2019-08-20 | Dana-Farber Cancer Institute, Inc. | Compostos no tratamento de neoplasia |
| RU2016105108A (ru) | 2013-07-25 | 2017-08-30 | Дана-Фарбер Кэнсер Инститьют, Инк. | Ингибиторы факторов транскрипции и их применение |
| RU2016122654A (ru) | 2013-11-08 | 2017-12-14 | Дана-Фарбер Кэнсер Инститьют, Инк. | Комбинированная терапия злокачественной опухоли с использованием ингибиторов бромодоменового и экстратерминального (вет) белка |
| JP2017504651A (ja) | 2014-01-31 | 2017-02-09 | ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド | ジアゼパン誘導体の使用 |
| KR20160115953A (ko) | 2014-01-31 | 2016-10-06 | 다나-파버 캔서 인스티튜트 인크. | 디아미노피리미딘 벤젠술폰 유도체 및 그의 용도 |
| SG11201607108XA (en) | 2014-02-28 | 2016-09-29 | Tensha Therapeutics Inc | Treatment of conditions associated with hyperinsulinaemia |
| CA2955074A1 (en) | 2014-08-08 | 2016-02-11 | Dana-Farber Cancer Institute, Inc. | Diazepane derivatives and uses thereof |
| JP2017525759A (ja) | 2014-08-08 | 2017-09-07 | ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド | ジヒドロプテリジノン誘導体およびその使用 |
| AU2015339511B2 (en) | 2014-10-27 | 2020-05-14 | Tensha Therapeutics, Inc. | Bromodomain inhibitors |
| EP3885343A1 (en) | 2014-11-06 | 2021-09-29 | Dana-Farber Cancer Institute, Inc. | Indole compounds as ezh2 inhibitors and uses thereof |
| KR20170098808A (ko) * | 2014-11-06 | 2017-08-30 | 다나-파버 캔서 인스티튜트 인크. | 이식편 대 숙주 질환 (gvhd)에 대한 염색질 구조를 조정하는 조성물의 용도 |
| WO2016200916A1 (en) * | 2015-06-08 | 2016-12-15 | Ansun Biopharma, Inc. | Treatment of human metapneumovirus |
| EP3307728A4 (en) | 2015-06-12 | 2019-07-17 | Dana Farber Cancer Institute, Inc. | ASSOCIATION THERAPY USING TRANSCRIPTION INHIBITORS AND KINASE INHIBITORS |
| CA2996974A1 (en) | 2015-09-11 | 2017-03-16 | Dana-Farber Cancer Institute, Inc. | Cyano thienotriazolodiazepines and uses thereof |
| PE20181086A1 (es) | 2015-09-11 | 2018-07-05 | Dana Farber Cancer Inst Inc | Acetamida tienotrizolodiazepinas y usos de las mismas |
| EP3380100A4 (en) | 2015-11-25 | 2019-10-02 | Dana-Farber Cancer Institute, Inc. | BIVALENT BROMODOMAIN INHIBITORS AND USES THEREOF |
| CN109069508A (zh) | 2016-04-22 | 2018-12-21 | 达纳-法伯癌症研究所股份有限公司 | Ezh2抑制剂及其用途 |
| MX2022006319A (es) * | 2019-11-25 | 2022-10-27 | Ansun Biopharma Inc | Suministro de celulas inmunitarias de sialidasa a celulas cancerosas, celulas inmunitarias y microambiente tumoral. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8245708B2 (en) * | 2002-05-07 | 2012-08-21 | The Research Foundation Of State University Of New York | Methods, devices and formulations for targeted endobronchial therapy |
| CN1700934B (zh) * | 2002-09-06 | 2011-08-03 | 菲利普莫里斯美国公司 | 液体气溶胶制剂和用于制备气溶胶的气溶胶产生装置及方法 |
| CA2506526C (en) | 2002-11-22 | 2017-04-18 | Mang Yu | Broad spectrum anti-viral therapeutics and prophylaxis |
| US7807174B2 (en) * | 2002-11-22 | 2010-10-05 | Nexbio, Inc. | Class of therapeutic protein based molecules |
| BRPI0706947B8 (pt) * | 2006-01-24 | 2021-05-25 | Ansun Biopharma Inc | método de preparação de uma composição de micropartícula |
| US8398971B2 (en) * | 2009-11-06 | 2013-03-19 | Nexbio, Inc. | Methods, compounds, and compositions for treatment and prophylaxis in the respiratory tract |
-
2013
- 2013-02-19 AU AU2013221230A patent/AU2013221230A1/en not_active Abandoned
- 2013-02-19 JP JP2014557870A patent/JP2015508780A/ja active Pending
- 2013-02-19 EP EP13749329.2A patent/EP2841092B1/en active Active
- 2013-02-19 CN CN201380009763.6A patent/CN104203267A/zh active Pending
- 2013-02-19 CN CN201811368987.7A patent/CN109529026A/zh active Pending
- 2013-02-19 US US13/770,991 patent/US20130280332A1/en not_active Abandoned
- 2013-02-19 WO PCT/US2013/026754 patent/WO2013123521A1/en active Application Filing
- 2013-02-19 CA CA2864746A patent/CA2864746A1/en not_active Abandoned
- 2013-02-19 ES ES13749329T patent/ES2970401T3/es active Active
-
2014
- 2014-08-13 IL IL234116A patent/IL234116B/en active IP Right Grant
-
2015
- 2015-01-26 US US14/605,572 patent/US20150132274A1/en not_active Abandoned
- 2015-09-04 HK HK15108646.4A patent/HK1207975A1/xx unknown
-
2017
- 2017-02-10 US US15/430,288 patent/US20170151315A1/en not_active Abandoned
- 2017-11-10 AU AU2017258955A patent/AU2017258955A1/en not_active Abandoned
-
2019
- 2019-09-05 AU AU2019226190A patent/AU2019226190B2/en not_active Ceased
-
2020
- 2020-03-10 IL IL273194A patent/IL273194B2/en unknown
- 2020-07-31 US US16/945,776 patent/US20210046165A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015508780A5 (ja) | ||
| IL273194B2 (en) | Methods, compounds and preparations for the treatment of parainfluenza virus in patients with a deficiency in the immune system | |
| BR112013028572B8 (pt) | Bocais para distribuição de droga nasal | |
| Harb et al. | Is Combihaler usable for aerosol delivery in single limb non-invasive mechanical ventilation? | |
| CN204502085U (zh) | 呼吸内科用喷药器 | |
| EA200802012A1 (ru) | Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением | |
| PH12014502662A1 (en) | Novel dosage form and formulation of abediterol | |
| MX2021012723A (es) | Inhalador de presión positiva para entrega de medicamento inhalable y métodos para uso. | |
| JP2014528470A5 (ja) | ||
| JP2014530231A5 (ja) | ||
| WO2012047182A3 (en) | Single dose dry powder inhalation device | |
| MX2021006585A (es) | Ciclosporina a en forma solubilizada en liposomas (l-csa) para usarse en el tratamiento de enfermedades pulmonares mediante la inhalación de un aerosol generado por un nebulizador. | |
| EA202091199A1 (ru) | Лекарственное средство для предотвращения или лечения риновирусной инфекции | |
| EA201201393A1 (ru) | Ингалятор, разработанный для доставки лекарственного средства в виде сухого порошка | |
| CN204092782U (zh) | 一种医用雾化器 | |
| NZ600208A (en) | Inhalation solutions | |
| JP2013522295A5 (ja) | ||
| MX2018013475A (es) | Acido carboxilico para tratar/prevenir congestion nasal. | |
| BR112013020632A8 (pt) | Composição farmacêutica para a administração tópica | |
| EA201201394A1 (ru) | Ингалятор для доставки лекарственного средства в виде сухого порошка | |
| CN203029815U (zh) | 呼吸内科用给药器 | |
| EP4005565A1 (en) | Novel uses of adamantane derivatives | |
| CN203436639U (zh) | 一种雾化器 | |
| AR094287A1 (es) | Metodos y composiciones para administracion de oxibutinina | |
| WO2021151005A9 (en) | Inhaled das181 to treat cancer in the lung |